CCMB ties up with Bengaluru-based company to research on COVID-19


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ CCMB ties up with Bengaluru-based company to research on COVID-19
Dr. Jogin Desai, CEO, Eyestem, expressed hope that CCMB will be able to leverage its platform and advance COVID-19 research that will help the country.

Centre for Cellular and Molecular Biology (CCMB), Hyderabad has tied up with a Bengaluru-based company, Eyestem Research Private Limited, to take up research activities on COVID-19. Through this research collaboration, an attempt will be made to grow novel coronavirus in human cell lines, which will enable in vitro testing of potential drugs and vaccines against the COVID-19.

Scientists of CCMB said, the research team will use Eyestem's human lung epithelial cell culture system provided as part of its Anti-COVID Screening (ACS) platform to understand the molecular and pathological characteristics of the novel coronavirus, with a view of establishing a rational basis for testing potential drugs in vitro. Dr. Rakesh Mishra, Director of CCMB said, culturing the virus outside the human host is a technological challenge that needs to be overcome.

Eyestem's cell culture system expresses the Angiotensin-converting enzyme 2, ACE2 receptor and other genes that are key determinants of viral entry and replication. He hoped that employing this system will allow the CCMB team led by Dr. Krishnan Harshan to grow the virus predictably and thereby open up the potential for the drug screening and vaccine development strategies.

CCMB is a constituent laboratory of the Council of Scientific and Industrial Research, CSIR known for its cutting-edge research work on cellular and molecular biology. Eyestem Research Private Limited is a cell therapy start-up incubated at the Centre for Cellular and Molecular Platforms, C-CAMP, Bengaluru. C-CAMP is an initiative of the Department of Biotechnology, Ministry of Science and Technology.

Dr. Jogin Desai, CEO, Eyestem, expressed hope that CCMB will be able to leverage its platform and advance COVID-19 research that will help the country. He said, the ACS platform has been developed by Dr. Rajarshi Pal and his team and is a testament to our depth and expertise in cell therapy and disease modeling. Dr Desai said, Eyestemis is working to democratize access to cell therapy as well as disease modeling platforms and bring their benefit to a large section of humanity.

Tags : #CCMB #Eyestem #Bengaluru #TieUp #Covid19

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026